Skip to main content
Menu
US

Norepinephrine, Levo-[ring-2,5,6-3H]-, 250µCi (9.25MBq)

Levo-Norepinephrine, tritiated on the ring group. Norepinephrine binds and activates adrenergic receptors, and is cleared by the norepinehprine transporter (NET).

For research use only. Not for use in diagnostic procedures

Product Variants
Part number: NET678250UC
Unit Size: 250 µCi
List price: USD 7,034.00
Your price: Login to view
USD 7,034.00
USD 7,034.00 /each
Part number: NET678005MC
Unit Size: 5 mCi
List price: USD 48,250.00
Your price: Login to view
USD 0.00
USD 48,250.00 /each

Overview

250 µCi quantities of Norepinephrine, Levo-[ring-2,5,6-3H]-. Norepinephrine (NA) is a neurotransmitter and hormone that increases heart rate and blood pressure, and is involved in the fight-or-flight response. It is widely used to treat low blood pressure.

We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.

Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NET678:

  1. Auch-Schwelk, W., Starke, K. and Steppeler, A. (1983), Experimental conditions required for the enhancement by α-adrenoceptor antagonists of noradrenaline release in the rabbit ear artery. British Journal of Pharmacology, 78: 543–551.
  2. Bryan-Lluka, L., Siebert, G. & Pond, S. (1999) Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn-Schmiedeberg's Arch Pharmacol, 360: 109.

Specifications

Molecular Weight
169.2
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Detection Method
Radiometric
Label Position
Specifically Labeled
One Unit Contains
250.0 µCi
Radioisotope
3H
Receptor Type
Adrenoceptors
Shipping Conditions
Shipped in Dry Ice
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Therapeutic Area
Cardiovascular
CNS & Neurologic
Metabolic Disorders
Unit Size
250 µCi

Resources

1-1 of 1 Resources
Calendar Icon
Calendar
2024 Fresh Lot Calendar

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Safety data sheet
+ Show more
Technical data sheet
+ Show more
Scroll Icon